Walker-Warburg syndrome

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Vajsar, Jiri ^a   Schachter, Harry ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GLYCOPROTEIN; MANNOSYLTRANSFERASE; PROTEIN O MANNOSYLTRANSFERASE; PROTEIN O-MANNOSYLTRANSFERASE;

BRAIN; CONGENITAL MALFORMATION; EYE MALFORMATION; FEMALE; GENETICS; HUMAN; INFANT; METHODOLOGY; MULTIPLE MALFORMATION SYNDROME; MUSCULAR DYSTROPHY; MUTATION; NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PROGNOSIS; REVIEW; SYNDROME;

ABNORMALITIES, MULTIPLE; BRAIN; CHILD, PRESCHOOL; DYSTROPHIN; EYE ABNORMALITIES; FEMALE; GLYCOPROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MANNOSYLTRANSFERASES; MUSCULAR DYSTROPHIES; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS; SYNDROME;

EID: 34248136577     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-29     Document Type: Review

References (48)

1. Lissencephaly. AE Walker, Arch Neurol Psychiat 1942 48 13 29
2. The heterogeneity of microphthalmia in the mentally retarded. M Warburg, Birth Defects Orig Art Ser 1971 7 136 154
3. Heterogeneity of congenital retinal non-attachment, falciform folds and retinal dysplasia. A guide to genetic counselling. M Warburg, Hum Hered 1976 26 137 148 950240
4. Hydrocephaly, congenital retinal nonattachment, and congenital falciform fold. M Warburg, Am J Ophthalmol 1978 85 88 94 413438
5. Diagnostic criteria for Walker-Warburg syndrome. WB Dobyns RA Pagon D Armstrong CJ Curry F Greenberg A Grix LB Holmes R Laxova VV Michels M Robinow RL Zimmerman, Am J Med Genet 1989 32 195 210 10.1002/ajmg.1320320213 2494887
6. Mutations in the O-Mannosyltransferase Gene POMT1 Give Rise to the Severe Neuronal Migration Disorder Walker-Warburg Syndrome. D Beltrán-Valero De Bernabé S Currier A Steinbrecher J Celli E Van Beusekom B Van Der Zwaag H Kayserili L Merlini D Chitayat WB Dobyns B Cormand AE Lehesjoki J Cruces T Voit CA Walsh H Van Bokhoven HG Brunner, Am J Hum Genet 2002 71 1033 1043 12369018 10.1086/342975
7. Glyc-O-genetics of Walker-Warburg syndrome. J van Reeuwijk HG Brunner H Van Bokhoven, Clin Genet 2005 67 281 289 10.1111/j.1399-0004.2004.00368.x 15733261
8. A homozygous nonsense mutation in the Fukutin gene causes a Walker-Warburg syndrome phenotype. D Beltrán-Valero de Bernabé E van Bokhoven E van Beusekom W Van Den Akker S Kant WB Dobyns B Cormand S Currier B Hamel B Talim H Topaloglu HG Brunner, J Med Genet 2003 40 845 848 10.1136/jmg.40.11.845 14627679
9. A new mutation of the fukutin gene in a non-Japanese patient. F Silan M Yoshioka K Kobayashi E Simsek M Tunc M Alper M Cam A Guven Fukuda M Kinoshita K Kocabay T Toda, Ann Neurol 2003 53 392 396 10.1002/ana.10491 12601708
10. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. D Beltran-Valero de Bernabe T Voit C Longman A Steinbrecher V Straub Y Yuva R Herrmann J Sperner C Korenke C Diesen WB Dobyns HG Brunner H van Bokhoven M Brockington F Muntoni, J Med Genet 2004 41 e61 10.1136/jmg.2003.013870 15121789
11. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J van Reeuwijk M Janssen C van den Elzen D Beltran-Valero de Bernabe P Sabatelli L Merlini M Boon H Scheffer M Brockington F Muntoni MA Huynen A Verrips CA Walsh PG Barth HG Brunner H van Bokhoven, J Med Genet 2005 42 907 912 10.1136/jmg.2005.031963 15894594
12. Genetic epidemiology of congenital muscular dystrophy in a sample from the north-east Italy. ML Mostacciuolo M Miorin F Martinello C Angelini P Perini CP Trevisan, Hum Genet 1996 97 277 279 10.1007/BF02185752 8786062
13. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. JM Ervasti K Ohlendieck SD Kahl MG Gaver KP Campbell, Nature 1990 345 315 319 10.1038/345315a0 2188135
14. Membrane organization of the dystrophin-glycoprotein complex. JM Ervasti KP Campbell, Cell 1991 66 1121 1131 10.1016/0092-8674(91)90035-W 1913804
15. The complexities of dystroglycan. SJ Winder, Trends Biochem Sci 2001 26 118 124 10.1016/S0968-0004(00)01731-X 11166570
16. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. RA Williamson MD Henry KJ Daniels RF Hrstka JC Lee Y Sunada O Ibraghimov-Beskrovnaya KP Campbell, Hum Mol Genet 1997 6 831 841 10.1093/hmg/6.6.831 9175728
17. A role for dystroglycan in basement membrane assembly. MD Henry KP Campbell, Cell 1998 95 859 870 10.1016/S0092-8674(00)81708-0 9865703
18. Characterization of dystroglycan-laminin interaction in peripheral nerve. H Yamada A Chiba T Endo A Kobata LV Anderson H Hori H Fukuta-Ohi I Kanazawa KP Campbell T Shimizu K Matsumura, J Neurochem 1996 66 1518 1524 8627307
19. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. A Chiba K Matsumura H Yamada T Inazu T Shimizu S Kusunoki I Kanazawa A Kobata T Endo, J Biol Chem 1997 272 2156 2162 10.1074/jbc.272.4.2156 8999917
20. O-mannosyl glycans in mammals. T Endo, Biochim Biophys Acta 1999 1473 237 246 10580142
21. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22-24 April The Netherlands. V Dubowitz M Fardeau, Neuromuscul Disord 1995 5 253 258 10.1016/0960-8966(95)90011-X 10712013
22. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. T Voit CA Sewry K Meyer R Hermann V Straub F Muntoni T Kahn R Unsold TR Helliwell R Appleton HG Lenard, Neuropediatrics 1995 26 148 155 7477753
23. Muscle-eye-brain disease: a neuropathological study. M Haltia I Leivo H Somer H Pihko A Paetau T Kivela A Tarkkanen F Tome E Engvall P Santavuori, Ann Neurol 1997 41 173 180 10.1002/ana.410410208 9029066
24. Severe classical congenital muscular dystrophy and merosin expression. J Vajsar D Chitayat LE Becker M Ho B Ben-Zeev V Jay, Clin Genet 1998 54 193 198 9788720
25. Muscle-eye-brain disease: clinical features, visual evoked potentials and brain imaging in 20 patients. P Santavuori L Valanne T Autti M Haltia H Pihko K Sainio, Eur J Paediatr Neurol 1998 2 41 47 10.1016/1090-3798(98)01004-1 10726845
26. Role of dystrophin isoforms and associated proteins in muscular dystrophy. KG Culligan AJ Mackey DM Finn PB Maguire K Ohlendieck, Int J Mol Med 1998 2 639 648 9850730
27. 68th ENMC international workshop (5th international workshop): On congenital muscular dystrophy, 9-11 April 1999, Naarden, The Netherlands. V Dubowitz, Neuromuscul Disord 1999 9 446 454 10.1016/S0960-8966(99)00074-7 10545052
28. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. B Cormand H Pihko M Bayes L Valanne P Santavuori B Talim R Gershoni-Baruch A Ahmad H van Bokhoven HG Brunner T Voit H Topaloglu WB Dobyns AE Lehesjoki, Neurology 2001 56 1059 1069 11320179
29. Glycosylation defects in inherited muscle disease. JE Hewitt PK Grewal, Cell Mol Life Sci 2003 60 251 258 10.1007/s000180300020 12678490
30. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. E Martin-Rendon DJ Blake, Trends Pharmacol Sci 2003 24 178 183 10.1016/S0165-6147(03)00050-6 12707004
31. Glycobiology of neuromuscular disorders. PT Martin HH Freeze, Glycobiology 2003 13 67R 75R 10.1093/glycob/cwg077 12736200
32. Glycosylation defects: a new mechanism for muscular dystrophy? PK Grewal J Hewitt, Hum Mol Genet 2003 12 Spec No 2 R259 264 10.1093/hmg/ddg272 12925572
33. Glycosylation in congenital muscular dystrophies. T Endo T Toda, Biol Pharm Bull 2003 26 1641 1647 10.1248/bpb.26.1641 14646163
34. Defective glycosylation in muscular dystrophy. F Muntoni M Brockington DJ Blake S Torelli SC Brown, Lancet 2002 360 1419 1421 10.1016/S0140-6736(02) 11397-3 12424008
35. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. A Yoshida K Kobayashi H Manya K Taniguchi H Kano M Mizuno T Inazu H Mitsuhashi S Takahashi M Takeuchi R Herrmann V Straub B Talim T Voit H Topaloglu T Toda T Endo, Dev Cell 2001 1 717 724 10.1016/S1534-5807(01)00070-3 11709191
36. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. K Taniguchi K Kobayashi K Saito H Yamanouchi A Ohnuma YK Hayashi H Manya DK Jin M Lee E Parano R Falsaperla P Pavone R Van Coster B Talim A Steinbrecher V Straub I Nishino H Topaloglu T Voit T Endo T Toda, Hum Mol Genet 2003 12 527 534 10.1093/hmg/ddg043 12588800
37. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. H Manya K Sakai K Kobayashi K Taniguchi M Kawakita T Toda T Endo, Biochem Biophys Res Commun 2003 306 93 97 10.1016/S0006-291X(03) 00924-0 12788071
38. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. J van Reeuwijk S Maugenre C van den Elzen A Virrips E Bertini F Muntoni L Merlini H Scheffer HG Brunner P Guicheney H van Bokhoven, Hum Mutat 2006 27 453 459 10.1002/humu.20313 16575835
39. Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome. SC Currier CK Lee BS Chang AL Bodell GS Pai L Job LG Lagae LI Al-Gazali WM Eyaid G Enns WB Dobyns CA Walsh, Am J Med Genet A 2005 133 53 57 15637732
40. Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation. K Akasaka-Manya H Manya T Endo, Biochem Biophys Res Commun 2004 325 75 79 10.1016/j.bbrc.2004.10.001 15522202
41. The twisted abdomen phenotype of Drosophila POMT1 and POMT2 mutants coincides with their heterophilic protein O-mannosyltransferase activity. T Ichimiya H Manya Y Ohmae H Yoshida K Takahashi R Ueda T Endo S Nishihara, J Biol Chem 2004 279 42638 42647 10.1074/jbc.M404900200 15271988
42. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. H Manya A Chiba A Yoshida X Wang Y Chiba Y Jigami RU Margolis T Endo, Proc Natl Acad Sci USA 2004 101 500 505 14699049 10.1073/pnas.0307228101
43. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. T Willer B Prados JM Falcon-Perez I Renner-Muller GK Przemeck M Lommel A Coloma MC Valero MH De Angelis W Tanner E Wolf S Strahl J Cruces, Proc Natl Acad Sci USA 2004 101 14126 14131 15383666 10.1073/pnas.0405899101
44. Prenatal diagnosis of Walker-Warburg syndrome in three sibs. B Gasser V Lindner M Dreyfus X Feidt P Leissner A Treisser C Stoll, Am J Med Genet 1998 76 107 110 10.1002/(SICI)1096-8628(19980305)76:2<107::AID-AJMG1>3.0.CO;2-Q 9511971
45. Prenatal diagnosis of retinal detachment in Walker-Warburg syndrome. SA Farrell A Toi ML Leadman RG Davidson C Caco, Am J Med Genet 1987 28 619 624 10.1002/ajmg.1320280309 3122570
46. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. SA Moore F Saito J Chen DE Michele MD Henry A Messing RD Cohn SE Ross-Barta S Westra RA Williamson T Hoshi KP Campbell, Nature 2002 418 422 425 10.1038/nature00838 12140559
47. Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker-Warburg syndrome caused by POMT1 mutation. P Sabatelli M Columbaro I Mura C Capanni G Lattanzi NM Maraldi D Beltran-Valero de Barnabe H van Bokoven S Squarzoni L Merlini, Biochim Biophys Acta 2003 1638 57 62 12757935
48. Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome. C Jimenez-Mallebrera S Torelli SC Brown L Feng M Brockington CA Sewry D Beltran-Valero De Bernabe F Muntoni, Eur J Paediatr Neurol 2003 7 129 137 10.1016/S1090-3798(03)00042-4 12788039